Skip to main content

Flovent News

Parents Scrambling After Asthma Inhaler Flovent Removed From Market

WEDNESDAY, Feb. 21, 2024 – A popular asthma inhaler was discontinued on Jan. 1, and the business move has left families scrambling to find a replacement for their kids. Flovent was one of the most...

Flovent Discontinuation in 2024 Raises Concerns for Doctors, Patients

FRIDAY, Dec. 29, 2023 – In a move that is causing concern among doctors and patients, GlaxoSmithKline is discontinuing Flovent (fluticasone inhalation) as of Jan. 1, 2024. The pharmaceutical company...

Flovent Asthma Inhaler Switch in 2024 Could Leave Some Patients Scrambling

FRIDAY, Dec. 29, 2023 — A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives. GSK, maker of the branded i...

Flovent Asthma Inhaler Switch in 2024 Could Leave Some Patients Scrambling

FRIDAY, Dec. 29, 2023 — A popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives. GSK, maker of the branded i...

Fluticasone Furoate Does Not Cut Time to COVID-19 Symptom Resolution

THURSDAY, Sept. 21, 2023 – For outpatients with mild-to-moderate COVID-19, inhaled fluticasone furoate does not shorten time to symptom resolution, according to a study published in the Sept. 21...

Teva Announces FDA Approval of ArmonAir RespiClick (fluticasone propionate) for Maintenance Treatment of Asthma

JERUSALEM--(BUSINESS WIRE) January 30, 2017 --Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved ArmonAir...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Asthma - Maintenance

Flovent patient information at Drugs.com